步长制药: 山东步长制药股份有限公司关于拟转让控股子公司股权的进展公告

Transaction Overview - The company plans to transfer 1% equity stakes in nine subsidiaries to Xie Jihui as part of its strategy to develop and integrate its health industry [1] - The subsidiaries involved in the equity transfer include Ningbo Buchang Trading Co., Ltd., Shandong Buchang Cosmetics Biotechnology Co., Ltd., Shandong Buchang Dingsheng Pharmaceutical Co., Ltd., Shandong Buchang Chuanfang Pharmaceutical Co., Ltd., Shandong Buchang Youpin Medical Technology Co., Ltd., Jinan Buchang Chicheng Trading Co., Ltd., Jinan Buchang Caigan Trading Co., Ltd., Jinan Buchang Yingxi Trading Co., Ltd., and Jinan Buchang Zhongfu Trading Co., Ltd. [1] Progress of the Transaction - The company and Xie Jihui have signed the equity transfer agreement and a supplementary cooperation agreement [2] - The transfer price for the equity stakes is set at 0 yuan, with Xie Jihui assuming the obligation for the paid-in capital of the transferred equity [2][3] - The completion of the equity transfer will be recognized upon the completion of the industrial and commercial change registration [3] Transitional Period and Responsibilities - A transitional period will be established from the signing of the agreement until the completion of the equity transfer, during which profits and losses will be shared according to the equity ratio [4] - Any breach of the agreement will require the breaching party to remedy the situation within 30 days of notification [4] Supplementary Agreement - The supplementary agreement clarifies that after the equity transfer, the company will no longer hold any rights or obligations related to the transferred equity [5] - The supplementary agreement and the original cooperation agreement together constitute the complete documentation for the transaction [5]